The Jakarta Post-Aug 13

The ongoing trial of a vaccine developed by Chinese biopharmaceutical firm Sinovac Biotech and state-owned pharmaceutical company PT Bio Farma on more than 1,600 volunteers has been good news for the country amid its battle against the pandemic.

Read more at: https://www.thejakartapost.com/academia/2020/08/13/overcoming-testing-disparity.html